The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference43 articles.
1. New therapies for ovarian cancer: cytotoxics and molecularly targeted agents;Dinh;Crit Rev Oncol Hematol,2008
2. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009
3. Ovarian cancer;Chobanian;Surg Clin North Am,2008
4. Alteration of cell-cycle regulation in epithelial ovarian cancer;Nam;Int J Gynecol Cancer,2008
5. Cell proliferation of human ovarian cancer is regulated by the opioid growth factor–opioid growth factor receptor axis;Donahue;Am J Physiol Regul Integr Comp Physiol,2009
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy;Cancers;2024-03-21
2. Role of Opioid Growth Factor-Opioid Growth Factor Receptor (OGF-OGFr) Axis in Cancer Management;J BIOL REG HOMEOS AG;2024
3. The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer;Advances in Neurobiology;2024
4. Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs;German Journal of Veterinary Research;2024-01
5. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3